
BioSig Technologies, Inc. (BSGM)
$
6.1
+1.65 (27.05%)
Key metrics
Financial statements
Free cash flow per share
-0.0157
Market cap
191.1 Million
Price to sales ratio
14.7 Thousand
Debt to equity
-0.0043
Current ratio
0.0265
Income quality
0.1663
Average inventory
0
ROE
41.2389
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
News

globenewswire.com
Partnership with Simplify Asset Management Unlocks Significant Opportunity for Demand of Streamex's Yield-Bearing Gold Token and additional tokenization opportunities with Simplify, AUM of $10,017,260,875 as of 09/15/2025 Partnership with Simplify Asset Management Unlocks Significant Opportunity for Demand of Streamex's Yield-Bearing Gold Token and additional tokenization opportunities with Simplify, AUM of $10,017,260,875 as of 09/15/2025

globenewswire.com
Partnership with Simplify Asset Management Unlocks Significant Opportunity for Demand of Streamex's Yield-Bearing Gold Token and additional tokenization opportunities with Simplify, AUM of $10,017,260,875 as of 09/15/2025 Partnership with Simplify Asset Management Unlocks Significant Opportunity for Demand of Streamex's Yield-Bearing Gold Token and additional tokenization opportunities with Simplify, AUM of $10,017,260,875 as of 09/15/2025

globenewswire.com
Strategic Rebranding to Focus on Expanded Business Model and Growth Strategy. New Ticker Symbol “STEX”. Strategic Rebranding to Focus on Expanded Business Model and Growth Strategy. New Ticker Symbol “STEX”.
globenewswire.com
Partnership unlocks exclusive tokenization rights, a four percent (4%) annual yield target on physical bullion, revenue share tied to leasing volumes and the creation of a groundbreaking institutionalized asset providing yield on physical gold holdings

globenewswire.com
Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ approval; Company operations, financings and closing of the merger transaction remain not impacted Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ approval; Company operations, financings and closing of the merger transaction remain not impacted

globenewswire.com
LOS ANGELES, CA & VANCOUVER, BC , Aug. 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), a gold tokenization infrastructure company building the foundation for on-chain gold markets, today announced that it will participate in the 5th annual Needham Virtual Crypto 1x1 Conference on September 4th, 2025. BioSig and Streamex CEO, Henry McPhie and CIO, Mitch Williams will host one on one meetings with institutional investors at the conference.

globenewswire.com
Offering Structured to Accelerate Streamex's Operational Build-Out, Strategically Allocated with No Warrants Offering Structured to Accelerate Streamex's Operational Build-Out, Strategically Allocated with No Warrants

globenewswire.com
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), today announced the pricing of its previously announced underwritten public offering of 3,852,149 shares of common stock at a public offering price of $3.90 per share. The offering is expected to close on or around August 15, 2025 subject to customary closing conditions. The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses are expected to be approximately $15,023,381.10. BioSig intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.

globenewswire.com
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”) which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM) today announced its intention to offer shares of common stock (or pre-funded warrants in lieu thereof) through an underwritten public offering. All of the shares of common stock (or pre-funded warrants in lieu thereof) are being offered by the Company. The completion of the offering remains subject to market conditions, with no assurance regarding its timing, size, or terms. The Company intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.

fool.com
Gold has always gravitated toward the world's deepest vaults, starting first with royal treasuries, then central banks, and now, apparently, blockchains. The latest flow is led by BioSig Technologies (BSGM -4.97%), which just said it would convert as much as $1.1 billion in physical gold bullion into crypto tokens on the Solana (SOL 3.10%) blockchain.
See all news